Network Pharmacology and Molecular Docking Study on the Mechanism of the Therapeutic Effect of Strychni Semen in NSCLC

Abstract Strychni Semen, characterized by its bitter taste and warm properties, has been confirmed to possess anti-tumor properties. However, the molecular mechanism of Strychni Semen in treating non-small cell lung cancer (NSCLC) needs further study. This study aimed to explore the molecular mechan...

Full description

Saved in:
Bibliographic Details
Main Authors: He Geng, Yujie Xue, Binghua Yan, Zhaoxue Lu, Hengjin Yang, Peng Li, Jundong Zhou
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Biological Procedures Online
Subjects:
Online Access:https://doi.org/10.1186/s12575-024-00259-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559830604546048
author He Geng
Yujie Xue
Binghua Yan
Zhaoxue Lu
Hengjin Yang
Peng Li
Jundong Zhou
author_facet He Geng
Yujie Xue
Binghua Yan
Zhaoxue Lu
Hengjin Yang
Peng Li
Jundong Zhou
author_sort He Geng
collection DOAJ
description Abstract Strychni Semen, characterized by its bitter taste and warm properties, has been confirmed to possess anti-tumor properties. However, the molecular mechanism of Strychni Semen in treating non-small cell lung cancer (NSCLC) needs further study. This study aimed to explore the molecular mechanism of Strychni Semen in treating NSCLC based on network pharmacology and molecular docking. The active components and targets of Strychni Semen were retrieved from the TCMSP, supplemented by the HERB database and the related literature. NSCLC-related targets were retrieved from the GeneCards, OMIM and DisGenet databases. The intersection targets of Strychni Semen in treating NSCLC were obtained via an online platform. The Protein-Protein Interaction (PPI) network was subsequently constructed to deeply analyse the interrelationship of the intersection targets via the String database. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were carried out via the Metascape database. The interactive networks between Strychni Semen and NSCLC were constructed via Cytoscape 3.9.1. Molecular docking detected interactions between the key components and the core targets. The core targets were validated via GEO datasets. 21 active components and 67 targets were identified, with 47 associated with NSCLC. The key active components were Stigmasterol, IcarideA, 2-Hydroxymethylanthraquinone, (+)-catechin, (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one, (S)-Stylopine, Brucine and Isobrucine. The core targets were PTGS2, NR3C1, ESR1, CASP3 and PRKACA. Molecular docking revealed that these compounds undergo strong binding affinity with the core genes. GEO database indicated that PTGS2 was the most promising core target. In addition, Strychni Semen’s effects on NSCLC involved mainly the Calcium pathway, the Estrogen pathway, and the cGMP-PKG and cAMP pathways. This study visually demonstrated the mechanism of the therapeutic effect of Strychni Semen in NSCLC through multiple components, targets and pathways which provides a basis for clinical treatment and further experimental research.
format Article
id doaj-art-98cd6ede65af49c3a15345e1584c0b83
institution Kabale University
issn 1480-9222
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series Biological Procedures Online
spelling doaj-art-98cd6ede65af49c3a15345e1584c0b832025-01-05T12:08:52ZengBMCBiological Procedures Online1480-92222024-12-0126111410.1186/s12575-024-00259-wNetwork Pharmacology and Molecular Docking Study on the Mechanism of the Therapeutic Effect of Strychni Semen in NSCLCHe Geng0Yujie Xue1Binghua Yan2Zhaoxue Lu3Hengjin Yang4Peng Li5Jundong Zhou6Department of Radiation Oncology, Huaian Hospital of Huaian City, Huaian Cancer HospitalDepartment of Pathology, Affiliated Huaian NO. 1 People’s Hospital of Nanjing Medical UniversityDepartment of Radiation Oncology, Huaian Hospital of Huaian City, Huaian Cancer HospitalDepartment of Radiation Oncology, Huaian Hospital of Huaian City, Huaian Cancer HospitalDepartment of Radiation Oncology, Huaian Hospital of Huaian City, Huaian Cancer HospitalDepartment of Radiation Oncology, Huaian Hospital of Huaian City, Huaian Cancer HospitalDepartment of Radiation Oncology, Nanjing Medical University Affiliated Suzhou HospitalAbstract Strychni Semen, characterized by its bitter taste and warm properties, has been confirmed to possess anti-tumor properties. However, the molecular mechanism of Strychni Semen in treating non-small cell lung cancer (NSCLC) needs further study. This study aimed to explore the molecular mechanism of Strychni Semen in treating NSCLC based on network pharmacology and molecular docking. The active components and targets of Strychni Semen were retrieved from the TCMSP, supplemented by the HERB database and the related literature. NSCLC-related targets were retrieved from the GeneCards, OMIM and DisGenet databases. The intersection targets of Strychni Semen in treating NSCLC were obtained via an online platform. The Protein-Protein Interaction (PPI) network was subsequently constructed to deeply analyse the interrelationship of the intersection targets via the String database. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were carried out via the Metascape database. The interactive networks between Strychni Semen and NSCLC were constructed via Cytoscape 3.9.1. Molecular docking detected interactions between the key components and the core targets. The core targets were validated via GEO datasets. 21 active components and 67 targets were identified, with 47 associated with NSCLC. The key active components were Stigmasterol, IcarideA, 2-Hydroxymethylanthraquinone, (+)-catechin, (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one, (S)-Stylopine, Brucine and Isobrucine. The core targets were PTGS2, NR3C1, ESR1, CASP3 and PRKACA. Molecular docking revealed that these compounds undergo strong binding affinity with the core genes. GEO database indicated that PTGS2 was the most promising core target. In addition, Strychni Semen’s effects on NSCLC involved mainly the Calcium pathway, the Estrogen pathway, and the cGMP-PKG and cAMP pathways. This study visually demonstrated the mechanism of the therapeutic effect of Strychni Semen in NSCLC through multiple components, targets and pathways which provides a basis for clinical treatment and further experimental research.https://doi.org/10.1186/s12575-024-00259-wStrychni semenNSCLCNetwork pharmacologyMolecular dockingSignaling pathway
spellingShingle He Geng
Yujie Xue
Binghua Yan
Zhaoxue Lu
Hengjin Yang
Peng Li
Jundong Zhou
Network Pharmacology and Molecular Docking Study on the Mechanism of the Therapeutic Effect of Strychni Semen in NSCLC
Biological Procedures Online
Strychni semen
NSCLC
Network pharmacology
Molecular docking
Signaling pathway
title Network Pharmacology and Molecular Docking Study on the Mechanism of the Therapeutic Effect of Strychni Semen in NSCLC
title_full Network Pharmacology and Molecular Docking Study on the Mechanism of the Therapeutic Effect of Strychni Semen in NSCLC
title_fullStr Network Pharmacology and Molecular Docking Study on the Mechanism of the Therapeutic Effect of Strychni Semen in NSCLC
title_full_unstemmed Network Pharmacology and Molecular Docking Study on the Mechanism of the Therapeutic Effect of Strychni Semen in NSCLC
title_short Network Pharmacology and Molecular Docking Study on the Mechanism of the Therapeutic Effect of Strychni Semen in NSCLC
title_sort network pharmacology and molecular docking study on the mechanism of the therapeutic effect of strychni semen in nsclc
topic Strychni semen
NSCLC
Network pharmacology
Molecular docking
Signaling pathway
url https://doi.org/10.1186/s12575-024-00259-w
work_keys_str_mv AT hegeng networkpharmacologyandmoleculardockingstudyonthemechanismofthetherapeuticeffectofstrychnisemeninnsclc
AT yujiexue networkpharmacologyandmoleculardockingstudyonthemechanismofthetherapeuticeffectofstrychnisemeninnsclc
AT binghuayan networkpharmacologyandmoleculardockingstudyonthemechanismofthetherapeuticeffectofstrychnisemeninnsclc
AT zhaoxuelu networkpharmacologyandmoleculardockingstudyonthemechanismofthetherapeuticeffectofstrychnisemeninnsclc
AT hengjinyang networkpharmacologyandmoleculardockingstudyonthemechanismofthetherapeuticeffectofstrychnisemeninnsclc
AT pengli networkpharmacologyandmoleculardockingstudyonthemechanismofthetherapeuticeffectofstrychnisemeninnsclc
AT jundongzhou networkpharmacologyandmoleculardockingstudyonthemechanismofthetherapeuticeffectofstrychnisemeninnsclc